What is Letrozole? Letrozole, marketed under the trade name Femara, embodies a pivotal pillar in the therapeutic armamentarium against breast cancer, particularly in post-menopausal women. This potent oral non-steroidal aromatase inhibitor (AI) signifies a cornerstone in the strategic disruption of estrogen synthesis, a critical driver in the progression of hormone-receptor-positive breast cancer. The inception of